Am J Transplant, Volume 20, Suppl 3 Archives - Page 86 of 223 - ATC Abstracts

2020 American Transplant Congress
Chronic Active T-Cell Mediated Rejection is Variably Responsive to Immunosuppressive Therapy
V. Kung¹, M. Haas¹, M. Gillespie², E. Huang², R. Sandhu²
¹Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, ²Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Chronic active T cell-mediated rejection (CACMR) is a newly described variant of kidney allograft rejection associated with long-term graft loss. A key histologic feature…
2020 American Transplant Congress
Simultaneous Laparoscopic Bilateral Native Nephrectomy and Open Kidney Transplantation in Patients with ESRD Due to ADPKD: A Single Center Experience
N. Abrol, A. Bentall, V. Torres, M. Prieto
Mayo Clinic, Rochester, MN
*Purpose: Patients with Autosomal Dominant Polycystic Kidney (ADPKD) progressing to end-stage renal disease (ESRD) often are symptomatic due to cystic kidneys and require surgical intervention.…
2020 American Transplant Congress
Effect of Simultaneous Presence of Anti-Blood Group A/B and -HLA Antibodies on Clinical Outcomes in Kidney Transplantation Across Positive Crossmatch: A Nationwide Cohort Study
H. Kwon, Y. Ko, D. Han
Department of General Surgery, Asan Medical Center, Seoul, Korea, Republic of
*Purpose: ABO-incompatible (ABOi) and positive crossmatch (XM) kidney transplantation (KT) have been considered immunologically challenging. The present study analyzed the clinical outcomes in XM positive…
2020 American Transplant Congress
Impact of Concentrations on Conversion from Twice‑Daily to Once‑Daily Tacrolimus in Stable Kidney Graft Recipients: A Single-Center Retrospective Study
Z. Wang, Y. Cao, Y. Fu
Transplant Surgery, Tianjin First Central Hospital, Tian Jin, China
*Purpose: Potential benefits of once-daily tacrolimus include improved adherence to immunosuppressives and decreased Intrapatient variability (IPV) post kidney transplantation. A retrospective analysis was performed to…
2020 American Transplant Congress
Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation
E. Palte¹, J. Duong², H. Remotti³, J. Burt³, A. Griesemer⁴, B. Samstein⁵, D. Marratta⁶, A. N. Fox⁷
¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY, ²Columbia University Mailman School of Public Health, New York, NY, ³Department of Pathology and Cell Biology, Columbia University, New York, NY, ⁴Department of Surgery, Columbia University, New York, NY, ⁵Department of Surgery, Weill Cornell Medicine, New York, NY, ⁶Department of Medicine, Columbia University, New York, NY, ⁷Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY
*Purpose: Living donor liver transplantation (LDLT) increases the donor pool and affords a life-saving cure to recipients who do not have MELD-based access to allografts.…
2020 American Transplant Congress
Rare Genetic Mutation Triggering Acute Liver Failure in a Toddler Needing a Liver Transplant
C. B. Chen¹, N. Mistry Ambani¹, A. Zeft¹, R. Garcia-Naviero², V. Hupertz¹, K. Hashimoto¹, K. Radhakrishnan¹
¹Cleveland Clinic, Cleveland, OH, ²Akron Children's Hospital, Akron, OH
*Purpose: The AIRE gene plays an important role in immune tolerance by driving negative selection of self-recognizing T-cells. Mutations in this gene are responsible for…
2020 American Transplant Congress
Changes in Risk Factors for Infections Post Liver Transplantation – A 16-Year Analysis
I. Bajjoka, S. Serra, J. Mourad, M. Callaghan, C. Crombez, S. Foley, M. Abouljoud
Transplant Institute, Henry Ford Hospital, Detroit, MI
*Purpose: Infections are common cause of morbidity and mortality post liver transplant (LT). Risk factors are related to donor and recipient factors, including cold ischemia…
2020 American Transplant Congress
The Clinical Impact of HCV D+/r- Kidney Transplantation
S. Meade¹, M. A. Simpson², E. D. Walshe², M. E. Akoad², F. D. Gordon²
¹Lahey Clinic, Burlington, MA, ²Transplantation, Lahey Clinic, Burlington, MA
*Purpose: Transplantation of hepatitis C (HCV) positive organs into HCV negative recipients raises concerns regarding potential for infections unresponsive to DAAs. In September 2018, we…
2020 American Transplant Congress
Patient and Renal Outcomes of Post Transplant Lymphoproliferative Disorder Following Solid Organ Transplantations – A Single Center Experience
G. Katz-Greenberg¹, K. Mallari², U. Martinez-Outschoorn¹, M. P. MartinezCantarin¹
¹Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, ²Thomas Jefferson University, Philadelphia, PA
*Purpose: Posttransplant lymphoproliferative disorder (PTLD) remains an unfortunate complication in patients following solid organ transplantation (SOT) and hematopoietic stem cells transplantations. The diagnosis of PTLD…
2020 American Transplant Congress
Public Health Insurance is Associated with Reduced Access to Living Donor Liver Transplantation and Increased Liver Transplant Waiting List Mortality: An Analysis of the SRTR
R. Hogen¹, M. Aljehani², J. Lee³, L. Sher¹, Y. Genyk¹, J. Emamaullee¹
¹Surgery, Division of Hepatobiliary and Abdominal Organ Transplant Surgery, University of Southern California, Los Angeles, CA, ²Surgery, University of Southern California, Los Angeles, CA, ³Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, CA
*Purpose: Living donor liver transplantation (LDLT) is associated with improved survival and lower hospital costs, but it continues to makes up less than 5% of…